Article

Effect of TO901317 on promoting the differentiation of human bone marrow mesenchymal stem cells into dopamine neurons on Parkinson's disease

2020-05-27

Abstract excerpt

<h4>Background: </h4> Stem cells from different sources could differentiate into dopamine-producing cells and ameliorate behavioral deficits in Parkinson's disease (PD) models. Especially, human bone marrow mesenchymal stem cells (hBMSCs) have many advantages without ethical dispute. Liver X receptors (LXRs) are involved in the maintenance of the normal function of the central nervous system myelin. The previous w...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2a1a848c-0b7b-57f9-af77-08b066d920f9
DOI: 10.21203/rs.3.rs-15406/v3

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Effect of TO901317 on promoting the differentiation of human bone marrow mesenchymal stem cells into dopamine neurons on Parkinson's diseaseDOI 10.21203/rs.3.rs-15406/v3Read

Synergetic Therapeutic Efficacy of Fasudil and Bone Marrow Derived-Neuronal Stem Cell in a Parkinson's Disease Mouse ModelSemantic proximity Read

Parkinson's Disease and Mesenchymal Stem Cells: Potential for Cell-Based TherapySemantic proximity Read

Induction of human mesenchymal stem cells into dopamine-producing cells with different differentiation protocols.Semantic proximity Read

Therapy With Mesenchymal Stem Cells in Parkinson DiseaseSemantic proximity Read

Directed Dopaminergic Neuron Differentiation from Human Pluripotent Stem CellsSemantic proximity Read

Therapeutic effects of umbilical cord MSC-derived induced neuronal cells in a rat Parkinson's modelSemantic proximity Read

22-hydroxycholesterol leads to efficient dopaminergic specification of human Mesenchymal Stem CellsSemantic proximity Read

Human embryonic stem cells overexpressing dopaminergic transcription factors survive and differentiate in the substantia nigra in vivoSemantic proximity Read

Treatment of Parkinson's disease using cell transplantationSemantic proximity Read

Autologous Versus Allogeneic iPSC-Derived Dopaminergic Neuron Therapy for Parkinson’s Disease: Molecular Mechanisms and Translational Trade-OffsSemantic proximity Read

Possible role of lncRNAs in amelioration symptoms in an animal model of Parkinson’s disease following transplantation of dopaminergic cells derived from stem cellsSemantic proximity Read

Dopaminergic Neurons Derived from Human Induced Pluripotent Stem Cells Survive and Integrate into 6-OHDA-Lesioned RatsSemantic proximity Read